Rajeev K Seth1, Paul A Gaudio. 1. Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Abstract
PURPOSE: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. DESIGN: Case report. RESULTS: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. CONCLUSIONS: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.
PURPOSE: To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis. DESIGN: Case report. RESULTS: A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up. CONCLUSIONS: Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.